ARCHIVES

Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023

This article is from The Cancer Letter archive.

Vol. 39 No. 46 | December 13, 2013

Download PDF Visit The Full Archive

Related Articles

Amgen, J&J Defend ESA Indications.

March 21, 2008

ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO.

June 1, 2007

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

In Brief: Baque Heads Cancer Control Science Programs; Joftes, Davignon T Retire; Schepartz Returns

September 29, 1989

Alan Rabson Named Acting NCI Director

October 5, 2001